$CCCC SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Anderson Kenneth Carl, Director Received 3,662 shares as a grant or award ($11.5K)
02 Oct 2026	Form 4: Grogan Donna Roy, Director Received 4,618 shares as a grant or award ($14.5K)
25 Sep 2026	8-K: Regulation FD Disclosure; Other Events Protein degraded. Disease targeted. Lives transformed. September 2026 Exhibit 99.2
21 Sep 2026	Form 4: Adams Kendra, Chief Financial Officer Received 6,250 shares by exercise or conversion · Gave up 2,775 shares to cover exercise price or tax ($9.41K)
14 Aug 2026	144
14 Aug 2026	144
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	144
12 Aug 2026	144
12 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
27 Jul 2026	SCHEDULE 13G
13 Jul 2026	Form 4: Reyno Leonard, Chief Medical Officer Received 15,325 shares by exercise or conversion · Gave up 7,397 shares to cover exercise price or tax ($30K)
02 Jul 2026	Form 4: Anderson Kenneth Carl, Director Received 2,650 shares as a grant or award ($11.5K)
02 Jul 2026	Form 4: Grogan Donna Roy, Director Received 3,341 shares as a grant or award ($14.5K)
26 Jun 2026	Form 4: Hughes Owen, Director Granted 62,000 Stock Option (Right to Buy)
26 Jun 2026	Form 4: Hoerter Steven L., Director Granted 62,000 Stock Option (Right to Buy)

Comments